Gut microbiota, inflammatory bowel disease and colorectal cancer.
Quaglio AEV, Grillo TG, De Oliveira ECS, Di Stasi LC, Sassaki LY.
World J Gastroenterol. 2022 Aug 14;28(30):4053-4060. doi: 10.3748/wjg.v28.i30.4053.
Carcinogenic microbiota and its role in colorectal cancer development.
Karpiński TM, Ożarowski M, Stasiewicz M.
Semin Cancer Biol. 2022 Nov;86(Pt 3):420-430. doi: 10.1016/j.semcancer.2022.01.004. Epub 2022 Jan 25.
Deferasirox alleviates DSS-induced ulcerative colitis in mice by inhibiting ferroptosis and improving intestinal microbiota.
Wu Y, Ran L, Yang Y, Gao X, Peng M, Liu S, Sun L, Wan J, Wang Y, Yang K, Yin M, Chunyu W.
Life Sci. 2023 Feb 1;314:121312. doi: 10.1016/j.lfs.2022.121312. Epub 2022 Dec 21.
Sickle Cell Disease.
Bender MA, Carlberg K.
2003 Sep 15 [updated 2025 Feb 13]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025.
Chronic streptococcal and non-streptococcal pharyngitis.
Murray RC, Chennupati SK.
Infect Disord Drug Targets. 2012 Aug;12(4):281-5. doi: 10.2174/187152612801319311.
Erythema nodosum.
Passarini B, Infusino SD.
G Ital Dermatol Venereol. 2013 Aug;148(4):413-7.
36th International Symposium on Intensive Care and Emergency Medicine : Brussels, Belgium. 15-18 March 2016.
Bateman RM, Sharpe MD, Jagger JE, Ellis CG, Solé-Violán J, López-Rodríguez M, Herrera-Ramos E, Ruíz-Hernández J, Borderías L, Horcajada J, González-Quevedo N, Rajas O, Briones M, Rodríguez de Castro F, Rodríguez Gallego C, Esen F, Orhun G, Ergin Ozcan P, Senturk E, Ugur Yilmaz C, Orhan N, Arican N, Kaya M, Kucukerden M, Giris M, Akcan U, Bilgic Gazioglu S, Tuzun E, Riff R, Naamani O, Douvdevani A, Takegawa R, Yoshida H, Hirose T, Yamamoto N, Hagiya H, Ojima M, Akeda Y, Tasaki O, Tomono K, Shimazu T, Ono S, Kubo T, Suda S, Ueno T, Ikeda T, Hirose T, Ogura H, Takahashi H, Ojima M, Kang J, Nakamura Y, Kojima T, Shimazu T, Ikeda T, Suda S, Izutani Y, Ueno T, Ono S, Taniguchi T, O M, Dinter C, Lotz J, Eilers B, Wissmann C, Lott R, Meili MM, Schuetz PS, Hawa H, Sharshir M, Aburageila M, Salahuddin N, Chantziara V, Georgiou S, Tsimogianni A, Alexandropoulos P, Vassi A, Lagiou F, Valta M, Micha G, Chinou E, Michaloudis G, Kodaira A, Ikeda T, Ono S, Ueno T, Suda S, Izutani Y, Imaizumi H, De la Torre-Prados MV, Garcia-De la Torre A, Enguix-Armada A, Puerto-Morlan A, Perez-Valero V, Garcia-Alcantara A, Bolton N, Dudziak J, Bonney S, Tridente A, Nee P, Nicolaes G, Wiewel M, Schultz M, Wildhag…
Crit Care. 2016 Apr 20;20(Suppl 2):94. doi: 10.1186/s13054-016-1208-6.
Immunopathogenesis of Behçet Disease.
Nieto IG, Alabau JLC.
Curr Rheumatol Rev. 2020;16(1):12-20. doi: 10.2174/1573397115666190415142426.
Behçet Disease: An Update for Dermatologists.
Alpsoy E, Bozca BC, Bilgic A.
Am J Clin Dermatol. 2021 Jul;22(4):477-502. doi: 10.1007/s40257-021-00609-4. Epub 2021 Jun 1.
[Characteristics of gastric mucosa microbiota in children with chronic gastritis and duodenal ulcer].
Zheng W, Peng KR, Li FB, Zhao H, Jiang LQ, Chen FB, Jiang MZ.
Zhonghua Er Ke Za Zhi. 2021 Jul 2;59(7):551-556. doi: 10.3760/cma.j.cn112140-20210331-00270.
